NASDAQ:SGNT (SGNT) (SGNT) Stock Price, News & Analysis → Biden replacement revealed? (From Paradigm Press) (Ad) Free SGNT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$21.76▼$21.7650-Day Range N/A52-Week Range$10.55▼$21.88VolumeN/AAverage Volume607,514 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (SGNT) alerts: Email Address Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About (SGNT) Stock (NASDAQ:SGNT)Sagent Pharmaceuticals, Inc. is a specialty and generic pharmaceutical company. The Company is a provider of pharmaceuticals to the hospital market, which it sells primarily throughout North America. It is focused on developing, manufacturing, sourcing and marketing injectable pharmaceutical products to the hospital market. It operates through two segments: Sagent US, consisting of the Company's operations in the United States and the Sagent (China) Pharmaceuticals Co. Ltd. (SCP) manufacturing facility, and Omega, which is focused on the Canadian and international markets. It offers a range of products across anti-infective, oncology and critical care indications in a range of presentations, including single and multi-dose vials, pre-filled ready-to-use syringes and premix bags. Its Sagent US product portfolio includes approximately 60 marketed products that it offers in over 180 presentations, and its Omega segment offers over 50 products.Read More Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now SGNT Stock News HeadlinesApril 22, 2024 | msn.comSan Jose fire captain among more than 20 arrested in child predator sting operationNovember 22, 2023 | msn.comFairfield man arrested in connection to Monday’s Vallejo shootingApril 25, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.August 22, 2023 | investing.comNihar Info Global Ltd (NIHR)May 8, 2023 | thestreet.comChanging Landscape for Generic-Drug Makers Creates OpportunitiesApril 30, 2023 | msn.comTrying to find someone to take out all the caulking around my windows outside and redo, replace some cedar siding and all corners have holes from woodpeckers.April 15, 2023 | msn.comOlivia Wilde will helm a tv adaptation of A Visit from the Goon SquadApril 4, 2023 | msn.comNo One Cares About Kamala HarrisApril 25, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.March 12, 2023 | msn.com'Please be patient': MBTA update on speed restrictionsMarch 10, 2023 | msn.comChicago River Dyeing 2023, St. Patrick's Day Parade To Take Place This WeekendFebruary 22, 2023 | technews.tmcnet.comLatticeFlow AG Appoints Global Technology Executive, Andre Boisvert, As Chairman of The BoardJanuary 2, 2023 | thestreet.comSagent Pharmaceuticals (SGNT) Soared Today on Nichi-Iko DealDecember 3, 2022 | msn.comWC Daily Preview: USA/NED, ARG/AUS open Round of 16September 20, 2022 | investing.comSalora International Ltd (SALI)September 15, 2022 | msn.comCharacter Designs That Drastically ChangedAugust 9, 2022 | msn.comJane Seymour hails close friend Olivia Newton-John for ‘changing the world’August 8, 2022 | msn.comWhat On Earth Will A Live-Action Pac-Man Movie Look Like?July 14, 2022 | investing.comSungold Capital Ltd (SUNG)December 2, 2021 | bbc.co.ukJeane Freeman: Inside The PandemicNovember 13, 2021 | dailymail.co.ukCleo Smith: Terrified neighbour of alleged doll-obsessed kidnapper fears locals will burn down houseNovember 11, 2021 | dailymail.co.ukCleo Smith: Forensics spray substance in Carnarvon, WA as Mark McGowan shoots down $1million rewardNovember 9, 2021 | dailymail.co.ukCar of Cleo Smith's alleged abductor becomes focus of investigation as officers scour phone recordsNovember 8, 2021 | msn.comHero detective who found missing girl Cleo Smith visits family homeNovember 8, 2021 | dailymail.co.ukHero detective who led Cleo Smith's rescue visits family home ahead of a week of crucial interviewsSee More Headlines Receive SGNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (SGNT) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/04/2015Today4/24/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryPharmaceuticals Current SymbolNASDAQ:SGNT CUSIP78669210 CIK1369786 Webwww.sagentpharma.com Phone+1-847-9081604FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report SGNT Stock Analysis - Frequently Asked Questions How were (SGNT)'s earnings last quarter? (SGNT) (NASDAQ:SGNT) released its quarterly earnings data on Tuesday, August, 4th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.05 by $0.06. The company had revenue of $77.30 million for the quarter, compared to analyst estimates of $83.28 million. The firm's quarterly revenue was up 11.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.09 EPS. What other stocks do shareholders of (SGNT) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (SGNT) investors own include Mazor Robotics (MZOR), Endocyte (ECYT), Inovio Pharmaceuticals (INO), Surgery Partners (SGRY), Allena Pharmaceuticals (ALNA), Catalyst Biosciences (CBIO), Chatham Lodging Trust (CLDT), CTI BioPharma (CTIC), Daré Bioscience (DARE) and Dynavax Technologies (DVAX). This page (NASDAQ:SGNT) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (SGNT) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.